BackSummary
NeuroOne Medical Technologies received Nasdaq notice confirming compliance with minimum bid price rule, closing the matter.
Key takeaways
- Company regained compliance with Nasdaq's $1.00 minimum bid price rule as of April 30, 2026.
- Compliance achieved after closing bid price remained at or above $1.00 for 10 consecutive business days.
- Nasdaq staff confirmed the matter is closed; no further action required.
- Previously received deficiency letter on May 6, 2025 due to bid price below $1.00 for 30 days.